Yi-Yun Ho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yi-Yun Ho has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Cheng-Hsien Wu
Oral & Maxillofacial Surgery, Department of Stomatology, Taipei Veterans General Hospital, Taipei 11217, Taiwan
2 shared publications Cheng‐Chieh Yang
Department of Stomatology, Oral & Maxillofacial Surgery, Taipei Veterans General Hospital, Taipei, Taiwan
1 shared publication- Ching-Po Lin
Institute of Neuroscience, National Yang Ming Chiao Tung University, Taipei, Taiwan
1 shared publication - Chun-Ju Lin
Department of Dentistry, School of Dentistry, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan
1 shared publication - Chun-Wei Hsu
Institute of Neuroscience, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan
1 shared publication Han‐Chieh Cheng
Department of Stomatology, Oral & Maxillofacial Surgery, Taipei Veterans General Hospital, Taipei, Taiwan
1 shared publication
Latest Publications
- Open Access
- 4 March 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (5) , 774
Artificial Intelligence for Preoperative Prediction of Lymph Node Metastasis and Depth of Invasion in Oral Tongue Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
Background: Occult lymph node metastasis (OLNM) and depth of invasion (DOI) are key determinants of elective neck dissection in clinically node-negative oral tongue squamous cell carcinoma (OTSCC), yet accurate preoperative risk stratification remains challenging. This study evaluated the diagnostic performance of artificial intelligence (AI)-based predictive models for OLNM and DOI in OTSCC. Methods: A systematic review and meta-analysis were conducted in accordance with PRISMA 2020 guidelines. A structured search of PubMed identified twelve eligible studies, nine of which provided extractable 2 × 2 contingency data for inclusion in the primary bivariate meta-analysis. One additional study modeling DOI-derived pT stage was synthesized narratively. Pooled sensitivity and specificity were estimated using a bivariate random-effects model. Heterogeneity, threshold effects, and publication bias (Deeks’ test) were assessed. Methodological quality was evaluated using QUADAS-2 supplemented by an AI-specific methodological appraisal. Results: Across nine studies included in the primary meta-analysis, pooled sensitivity was 0.679 (95% CI: 0.604–0.745) and pooled specificity was 0.762 (95% CI: 0.705–0.811), with a summary AUC of 0.786. Heterogeneity was moderate for sensitivity (I2 = 41.8%) and low for specificity (I2 = 23.4%), with no significant threshold effect (ρ = −0.117, p = 0.776). No significant publication bias was detected (p = 0.596). Subgroup analyses showed comparable performance between OLNM-specific and general LNM models, whereas deep learning or hybrid approaches demonstrated higher accuracy than traditional machine learning methods. Notably, only one out of nine primary studies incorporated true external validation. Conclusions: AI-based models demonstrate moderate discriminative performance for predicting LNM and DOI in OTSCC and may serve as adjunctive tools in preoperative risk stratification rather than standalone decision-makers. However, the near absence of external validation, limited calibration reporting, and lack of clinician-comparator analyses substantially constrain current clinical translation. Future research should prioritize multi-center prospective validation, systematic calibration and decision-curve analyses, and adherence to TRIPOD-AI and CLAIM reporting standards.
- 4 March 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (5) , 774
Open AccessArtificial Intelligence for Preoperative Prediction of Lymph Node Metastasis and Depth of Invasion in Oral Tongue Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
Background: Occult lymph node metastasis (OLNM) and depth of invasion (DOI) are key determinants of elective neck dissection in clinically node-negative oral tongue squamous cell carcinoma (OTSCC), yet accurate preoperative risk stratification remains challenging. This study evaluated the diagnostic performance of artificial intelligence (AI)-based predictive models for OLNM and DOI in OTSCC. Methods: A systematic review and meta-analysis were conducted in accordance with PRISMA 2020 guidelines. A structured search of PubMed identified twelve eligible studies, nine of which provided extractable 2 × 2 contingency data for inclusion in the primary bivariate meta-analysis. One additional study modeling DOI-derived pT stage was synthesized narratively. Pooled sensitivity and specificity were estimated using a bivariate random-effects model. Heterogeneity, threshold effects, and publication bias (Deeks’ test) were assessed. Methodological quality was evaluated using QUADAS-2 supplemented by an AI-specific methodological appraisal. Results: Across nine studies included in the primary meta-analysis, pooled sensitivity was 0.679 (95% CI: 0.604–0.745) and pooled specificity was 0.762 (95% CI: 0.705–0.811), with a summary AUC of 0.786. Heterogeneity was moderate for sensitivity (I2 = 41.8%) and low for specificity (I2 = 23.4%), with no significant threshold effect (ρ = −0.117, p = 0.776). No significant publication bias was detected (p = 0.596). Subgroup analyses showed comparable performance between OLNM-specific and general LNM models, whereas deep learning or hybrid approaches demonstrated higher accuracy than traditional machine learning methods. Notably, only one out of nine primary studies incorporated true external validation. Conclusions: AI-based models demonstrate moderate discriminative performance for predicting LNM and DOI in OTSCC and may serve as adjunctive tools in preoperative risk stratification rather than standalone decision-makers. However, the near absence of external validation, limited calibration reporting, and lack of clinician-comparator analyses substantially constrain current clinical translation. Future research should prioritize multi-center prospective validation, systematic calibration and decision-curve analyses, and adherence to TRIPOD-AI and CLAIM reporting standards.
- 23 April 2019
- Published by Wiley in Head & Neck
- Vol. 41 (9) , 2991-3001
The significance of tumor budding in oral cancer survival and its relevance to the eighth edition of the American Joint Committee on Cancer staging system
Background: To explore the clinicopathological significance of tumor budding (TB) on oral squamous cell carcinoma (OSCC) prognosis.Methods: Data of 200 patients with OSCC were retrieved from the cancer registration database in Taipei Veterans General Hospital. Clinicopathological characteristics and survival relevant to TB were analyzed.Results: The data showed that TB was predominant in the tongue and floor of the mouth in younger patients with OSCC and correlated with several pathological factors, such as perineural invasion and lymphovascular invasion. Patients with TB have significantly lower recurrence‐free survival (P ≤ .0001). TB was significantly associated with lymph node metastasis in patients with early cancer stage (P = .042). Multivariate analysis demonstrated extranodal extension and TB as independent predictors of lymph node recurrence (adjusted hazard ratio = 9.90 and 3.89, respectively).Conclusion: TB is a significant predictor of tumor aggression with locoregional failure even in the revised 8th American Joint Committee on Cancer staging system.
- 23 April 2019
- Published by Wiley in Head & Neck
- Vol. 41 (9) , 2991-3001
The significance of tumor budding in oral cancer survival and its relevance to the eighth edition of the American Joint Committee on Cancer staging system
Background: To explore the clinicopathological significance of tumor budding (TB) on oral squamous cell carcinoma (OSCC) prognosis.Methods: Data of 200 patients with OSCC were retrieved from the cancer registration database in Taipei Veterans General Hospital. Clinicopathological characteristics and survival relevant to TB were analyzed.Results: The data showed that TB was predominant in the tongue and floor of the mouth in younger patients with OSCC and correlated with several pathological factors, such as perineural invasion and lymphovascular invasion. Patients with TB have significantly lower recurrence‐free survival (P ≤ .0001). TB was significantly associated with lymph node metastasis in patients with early cancer stage (P = .042). Multivariate analysis demonstrated extranodal extension and TB as independent predictors of lymph node recurrence (adjusted hazard ratio = 9.90 and 3.89, respectively).Conclusion: TB is a significant predictor of tumor aggression with locoregional failure even in the revised 8th American Joint Committee on Cancer staging system.